NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Spartex:

You misunderstand my post. I am not claiming that the trial has failed. I am making the following points:

1. Top line will probably be positive but not as good as many have hopes for. As LP has said, this is new pioneering ground and there is no clear pathway. They are amending the SAPs in face of this realty. I don't think the results will be completely undeniable and irrefutable, but I believe, in due course, that reg approvals will issue, probably in late 2021/early 2022. Due to all this, share appreciation will be capped. There will be financing concerns and the sale of their last tangible asset on the way to achieving reg approvals;

2. Letting ASCO come and go with essentially a "nothing burger" is a recipe for share price disaster. Hopefully, NWBO management is prescient enough to understand this and avoid this outcome.

JMHO.